D. Angus

发表

Organization and management of critical care systems in unconventional situations.

D. Angus, V. Kvetan, 1993, Critical care clinics.

The effect of managed care on ICU length of stay: implications for medicare.

J. Lave, C. Sirio, D. Angus, 1996, JAMA.

Community-wide assessment of intensive care outcomes using a physiologically based prognostic measure: implications for critical care delivery from Cleveland Health Quality Choice.

A J Rotondi, D L Harper, C. Sirio, 1999, Chest.

Cleveland Health Quality Choice (CHQC)--an ongoing collaborative, community-based outcomes assessment program.

C. Sirio, D. Angus, G. Rosenthal, 1994, New horizons.

A Learning Health System Randomized Trial of Monoclonal Antibodies for Covid-19

C. Seymour, G. Snyder, D. Angus, 2021, medRxiv.

Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trial

C. Seymour, G. Snyder, D. Angus, 2021, medRxiv.

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis

J. Luketich, J. Mellors, D. Angus, 2021, medRxiv.

Trial of nurse practitioners in intensive care.

E. Sinz, C. Sirio, D. Angus, 1994, New horizons.

Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19.

David T. Huang, C. Seymour, D. Yealy, 2021, medRxiv.

Cost effectiveness of drotrecogin alfa ( activated ) for the treatment of severe sepsis in the United Kingdom

D. Angus, J. Hutton, S. Ridley, 2019 .